Scandion Oncology has been awarded an InnoBoster grant from Innovation Fund Denmark to conduct further research with its leading drug SCO-101.
Scandion Oncology has been awarded an InnoBoster grant from Innovation Fund Denmark to conduct further research with its leading drug SCO-101.